Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2009
09/10/2009US20090227624 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
09/10/2009US20090227623 Deuterium-enriched palosetron
09/10/2009US20090227622 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders
09/10/2009US20090227621 Naphthyridine derivatives having inhibitory activity against hiv integrase
09/10/2009US20090227620 Anti-inflammatory compounds
09/10/2009US20090227619 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo
09/10/2009US20090227618 Carboline Derivatives Useful in the Inhibition of Angiogenesis
09/10/2009US20090227617 Esters Of Glucuronide Prodrugs Of Anthracyclines And Method Of Preparation And Use In Tumor-Selective Chemotherapy
09/10/2009US20090227616 Inhibitors of akt activity
09/10/2009US20090227615 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
09/10/2009US20090227614 Modulators of Muscarinic Receptors
09/10/2009US20090227613 Novel 3-Aza-Spiro[5.5]Undecane Derivatives and Their Use As Monoamine Neurotransmitter Re-Uptake Inhibitors
09/10/2009US20090227612 Aminopyrimidine Derivatives Inhibiting Protein Kinase Activity, Method For The Preparation Thereof And Pharmaceutical Composition Containing Same
09/10/2009US20090227611 Crystal form of phenylamino pyrimidine derivatives
09/10/2009US20090227610 Novel triglyceride reducing agent
09/10/2009US20090227609 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
09/10/2009US20090227608 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia
09/10/2009US20090227607 Deazapurines useful as inhibitors of janus kinases
09/10/2009US20090227606 Methods for Preventing or Treating Acute and Chronic Pain
09/10/2009US20090227605 Enhanced efficacy benzisoxazole derivative dosage forms and methods
09/10/2009US20090227604 Vitamin d receptor modulators
09/10/2009US20090227603 Leukotriene b4 inhibitors
09/10/2009US20090227602 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
09/10/2009US20090227601 Bradykinin 1 Receptor Antagonists
09/10/2009US20090227600 4-(pyrazine-2-yl) -pyrrolidine -2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
09/10/2009US20090227599 Sulfonyl-substituted bicyclic compounds as modulators of ppar
09/10/2009US20090227598 Ret Tyrosine Kinase Inhibition
09/10/2009US20090227597 Pyrazolopyrimidinones as phosphodiesterase inhibitors
09/10/2009US20090227596 Heteroaryl nitrile derivatives
09/10/2009US20090227595 Glycine transporter-1 inhibitors
09/10/2009US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
09/10/2009US20090227593 Cyclobutyl amine derivatives
09/10/2009US20090227592 Compounds effecting glucokinase
09/10/2009US20090227591 Cyclopentene compounds
09/10/2009US20090227590 Quaternary ammonium salts as m3 antagonists
09/10/2009US20090227589 Pyrazole derivatives as sigma receptors antagonists
09/10/2009US20090227588 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors
09/10/2009US20090227587 Pyrimidines as inhibitors of phosphoinositide-3-kinases (PI3K)
09/10/2009US20090227586 2-anilino-4-(heterocyclic)amino-pyrimidines
09/10/2009US20090227585 Substituted n-heterocycle derivatives and methods of their use
09/10/2009US20090227584 2-aminoquinoline derivatives
09/10/2009US20090227583 2-aminoquinolines
09/10/2009US20090227582 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
09/10/2009US20090227581 such as 3-[3-(4-tert-Butyl-[1,2,3]triazol-1-yl)-1-(tetrahydro-pyran-4-yl)-propyl]-7-ethoxy-6-(2-fluoro-phenyl)-quinolin-2-ylamine, used in the treatment of Alzheimer's disease (AD), mild cognitive impairment, senility and/or dementia
09/10/2009US20090227580 Bicyclic derivatives as CETP inhibitors
09/10/2009US20090227579 Pteridine Derivatives and their Use as Cathespin Inhibitors
09/10/2009US20090227578 Azabenzimidazole Derivatives, Their Manufacture and Use as Anti-Cancer Agents
09/10/2009US20090227577 Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
09/10/2009US20090227576 2-alkylbenzoxazole carboxamides as 5ht3 modulators
09/10/2009US20090227575 7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS
09/10/2009US20090227574 Administration of Carboline Derivatives Useful in the Treatment of Cancer and Other Diseases
09/10/2009US20090227573 Substituted cyclopentanes having prostaglandin activity
09/10/2009US20090227572 Treatment of diabetic wounds and peripheral neuropathies
09/10/2009US20090227571 Androgen Receptor Modulator Compounds and Methods
09/10/2009US20090227570 2-aminoquinolines
09/10/2009US20090227569 Pyrrolidine derivatives
09/10/2009US20090227568 Methods and compositions for the delivery of a therapeutic agent
09/10/2009US20090227567 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
09/10/2009US20090227566 Such as N-(4-Chlorophenyl)-2-[4-(N,N-dimethylamino)-2-(piperidin-4-yloxy)-benzoylamino]benzamide; Factor Xa inhibitors
09/10/2009US20090227565 Biphenyl Vasopressin Agonists
09/10/2009US20090227564 Drug for prevention and/or therapy of endometriosis
09/10/2009US20090227562 Combination of a Selective Noradrenaline Reuptake Unhibitor and a PDEV Inhibitor
09/10/2009US20090227561 Fused heterocyclic derivative and use thereof
09/10/2009US20090227560 Substituted imidazole compound and use thereof
09/10/2009US20090227559 Snps in the apob gene and susceptibility to increased levels of alat following ximelagatran administration
09/10/2009US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase
09/10/2009US20090227557 Substituted beta-lactams
09/10/2009US20090227556 Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives
09/10/2009US20090227555 Novel Pyridine Compounds
09/10/2009US20090227554 Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens
09/10/2009US20090227553 Synthesis of chlorins and phorbines with enhanced red spectral features
09/10/2009US20090227552 Fulvestrant formulations
09/10/2009US20090227551 Therapeutic Uses of Steroidal Compounds
09/10/2009US20090227550 Controlled release delivery system for nasal application of neurotransmitters
09/10/2009US20090227549 Fulvestrant formulations
09/10/2009US20090227548 Novel Glucocorticoid Receptor Agonists
09/10/2009US20090227547 Novel salt form of a Beta2-adrenergic agonist quinolin-2-one derivative
09/10/2009US20090227546 Pharmaceutical composition of drospirenone and ethynylestradiol
09/10/2009US20090227545 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound
09/10/2009US20090227544 Bone Targeted Therapeutics and Methods of Making and Using the Same
09/10/2009US20090227543 Phosphonate compounds having immuno-modulatory activity
09/10/2009US20090227542 Novel Boronic Chalcone Derivatives and Uses Thereof
09/10/2009US20090227541 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics
09/10/2009US20090227539 Boron compounds useful in bnct
09/10/2009US20090227538 N-(Hetero)Aryl Indole Derivatives as Pesticides
09/10/2009US20090227537 Sulfated polysaccharides and uses thereof in medical treatment
09/10/2009US20090227536 Compositions comprising pectin and ascorbic acid
09/10/2009US20090227535 Process for producing natural immunobiotic extract and uses thereof
09/10/2009US20090227534 Pharmaceutical Composition Comprising the Combination of a Ketorolac Salt and Vitamins of the-B-Complex for the Treatment of Neuralgia
09/10/2009US20090227533 miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention
09/10/2009US20090227532 Analogues of Coformycin and Their Use for Treating Protozoan Parasite Infections
09/10/2009US20090227531 Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death
09/10/2009US20090227530 Sodium channel blockers
09/10/2009US20090227529 Combination treatment for bladder cancer
09/10/2009US20090227528 Pulmonary administration of an antithrombotic compound
09/10/2009US20090227527 Pharmaceutical composition for preventing and/or treating bone disease, functional food or health food and pharmaceutical preparation comprising thereof as active ingredient
09/10/2009US20090227526 Cytoprotective composition comprising hesperidin or pharmaceutically acceptable salt thereof as an active ingredient
09/10/2009US20090227525 Wrinkle-diminishing agent
09/10/2009US20090227524 Antiviral therapeutic agents
09/10/2009US20090227523 Use of compatible solutes as substances having free radical scavenging properties
1 ... 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 ... 7860